Home › Acute Lymphoblastic Leukemia
Pag-aaral pangklinika para sa Acute Lymphoblastic Leukemia na nagre-recruit sa U.S.
137 pag-aaral para sa Acute Lymphoblastic Leukemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX28 pag-aaral
- New York City, NY22 pag-aaral
- Seattle, WA22 pag-aaral
- Baldwin Park, CA21 pag-aaral
- Atlanta, GA20 pag-aaral
- Chicago, IL20 pag-aaral
- Memphis, TN17 pag-aaral
- Philadelphia, PA16 pag-aaral
- Washington, DC16 pag-aaral
- Los Angeles, CA15 pag-aaral
- Boston, MA15 pag-aaral
- Mountain View, CA14 pag-aaral
- Durham, NC13 pag-aaral
- Cincinnati, OH13 pag-aaral
- Minneapolis, MN12 pag-aaral
- Columbus, OH11 pag-aaral
- Tampa, FL10 pag-aaral
- Salt Lake City, UT10 pag-aaral
- Portland, OR9 pag-aaral
- Aurora, CO9 pag-aaral
- Charlotte, NC9 pag-aaral
- Baltimore, MD9 pag-aaral
- Edison, NJ9 pag-aaral
- Nashville, TN8 pag-aaral
- San Antonio, TX8 pag-aaral
- Cleveland, OH8 pag-aaral
- Miami, FL8 pag-aaral
- St. Louis, MO7 pag-aaral
- Birmingham, AL7 pag-aaral
- Denver, CO7 pag-aaral
- Phoenix, AZ6 pag-aaral
- San Diego, CA6 pag-aaral
- Detroit, MI6 pag-aaral
- Milwaukee, WI6 pag-aaral
- Queens, NY6 pag-aaral
- Oklahoma City, OK6 pag-aaral
- Pittsburgh, PA6 pag-aaral
- Cedar Rapids, IA5 pag-aaral
- The Bronx, NY5 pag-aaral
- Indianapolis, IN5 pag-aaral
Ayos sa estado
- Alabama7 pag-aaral
- Arizona7 pag-aaral
- Arkansas5 pag-aaral
- California41 pag-aaral
- Colorado13 pag-aaral
- Connecticut4 pag-aaral
- District of Columbia10 pag-aaral
- Florida19 pag-aaral
- Georgia21 pag-aaral
- Hawaii3 pag-aaral
- Illinois21 pag-aaral
- Indiana6 pag-aaral
- Iowa5 pag-aaral
- Kansas5 pag-aaral
- Kentucky4 pag-aaral
- Louisiana6 pag-aaral
- Maine3 pag-aaral
- Maryland16 pag-aaral
- Massachusetts15 pag-aaral
- Michigan8 pag-aaral
- Minnesota14 pag-aaral
- Mississippi3 pag-aaral
- Missouri7 pag-aaral
- Nebraska4 pag-aaral
- Nevada3 pag-aaral
- New Jersey11 pag-aaral
- New Mexico3 pag-aaral
- New York30 pag-aaral
- North Carolina22 pag-aaral
- Ohio23 pag-aaral
- Oklahoma8 pag-aaral
- Oregon10 pag-aaral
- Pennsylvania21 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina5 pag-aaral
- South Dakota3 pag-aaral
- Tennessee23 pag-aaral
- Texas30 pag-aaral
- Utah10 pag-aaral
- Virginia9 pag-aaral
- Washington23 pag-aaral
- West Virginia4 pag-aaral
- Wisconsin9 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07109219A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Nagre-recruitPhase 1
Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06173518A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Nagre-recruit
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT05621291Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07572136TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Nagre-recruitPhase 1/2
Hanggang edad 1 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05848687Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06308588Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT03263572HPC Offered for PRESERVE Expansion
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07145411Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069Auto Stem Cell Transplant for Lymphoma Patients
Nagre-recruitPhase 2
Hanggang edad 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT03125642Feasibility and Acceptability of Remote Saliva Collection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 8 hanggang 18 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07884474Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
Nagre-recruitPhase 1
Edad 3 hanggang 35 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT02390752Personalized NK Cell Therapy in CBT
Nagre-recruitPhase 2
Edad 15 hanggang 80 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT02727803Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06904066Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Hanggang edad 50 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT05322850225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06287944A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07614022Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06131801Prophylactic DLI-X for Leukemia Relapse After HCT
Nagre-recruitPhase 1
Hanggang edad 65 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07254793Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT01137643Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Nagre-recruitPhase 1
7 Months – 21 Years · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT02508038Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Nagre-recruitPhase 2
6 Months – 65 Years · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06013423CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Nagre-recruitPhase 1/2
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT05442515CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Nagre-recruitPhase 2
Edad 3 hanggang 65 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07328503CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT06059391Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.